<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04429178</url>
  </required_header>
  <id_info>
    <org_study_id>2020-00774; qu19Buddeberg</org_study_id>
    <nct_id>NCT04429178</nct_id>
  </id_info>
  <brief_title>Portal Vein Pulsatility Flow in Pregnancy</brief_title>
  <official_title>Portal Vein Pulsatility Flow in Pregnancy - a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to investigate if portal vein pulsatility fraction can be measured in pregnancy
      and if it increases during the course of pregnancy as would be expected by the physiologic
      increase in blood volume that happens during pregnancy. Portal vein pulsatility fraction is
      measured in non-pregnant controls and in women in the 1st, 2nd and 3rd trimester of
      pregnancy.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 2020</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Portal vein pulsatility fraction (percent)</measure>
    <time_frame>single time-point at baseline</time_frame>
    <description>Portal vein pulsatility fraction (percent)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Inferior vena cava diameter (mm)</measure>
    <time_frame>single time-point at baseline</time_frame>
    <description>Inferior vena cava diameter (mm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inferior vena cava collapsibility index (percent)</measure>
    <time_frame>single time-point at baseline</time_frame>
    <description>Inferior vena cava collapsibility index (percent)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hepatic venous flow (cm/sec)</measure>
    <time_frame>single time-point at baseline</time_frame>
    <description>Hepatic venous flow (cm/sec)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Right atrial and ventricular dimensions (cm)</measure>
    <time_frame>single time-point at baseline</time_frame>
    <description>Right atrial and ventricular dimensions (cm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tricuspid Annular Plane Systolic Excursion (TAPSE) (mm)</measure>
    <time_frame>single time-point at baseline</time_frame>
    <description>Tricuspid Annular Plane Systolic Excursion (TAPSE) (mm)</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>women in the 1st trimester of pregnancy.</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>women in the 2nd trimester of pregnancy.</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>women in the 3rd trimester of pregnancy.</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>non-pregnant women</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ultrasound</intervention_name>
    <description>portal vein pulsatility fraction (percent) measured with ultrasound</description>
    <arm_group_label>non-pregnant women</arm_group_label>
    <arm_group_label>women in the 1st trimester of pregnancy.</arm_group_label>
    <arm_group_label>women in the 2nd trimester of pregnancy.</arm_group_label>
    <arm_group_label>women in the 3rd trimester of pregnancy.</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant women attending either the anaesthetic preassessment clinic or the obstetric
        ultrasound clinic at University Hospital Basel.

        Non-pregnant healthy females fulfilling the inclusion criteria will be recruited by
        published advertisement at the University Hospital Basel.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ability to give informed consent

          -  American Society of Anesthesiologists (ASA) Class I and II

          -  Singleton pregnancy during 1st, 2nd or 3rd trimester or healthy non-pregnant females
             of childbearing age as controls

        Exclusion Criteria:

          -  Inability to give informed consent

          -  Multiple gestation

          -  Significant co-morbidities (e.g. cardiac abnormalities, cardiac dysfunction,
             arrhythmias, severe asthma, renal insufficiency)

          -  High risk pregnancies (e.g. pre-eclampsia, gestational hypertension, HELLP,
             gestational diabetes)

          -  Body-Mass-Index (BMI) &lt; 18kg/m2 or &gt;40kg/m2
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bigna Buddeberg, Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesiology, University Hospital Basel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bigna Buddeberg, Dr. med.</last_name>
    <phone>+41 61 328 6417</phone>
    <email>bigna.buddeberg@usb.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Anesthesiology, University Hospital Basel</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <contact>
      <last_name>Bigna Buddeberg, Dr. med.</last_name>
      <phone>+41 61 328 6417</phone>
      <email>bigna.buddeberg@usb.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 9, 2020</study_first_submitted>
  <study_first_submitted_qc>June 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 12, 2020</study_first_posted>
  <last_update_submitted>June 9, 2020</last_update_submitted>
  <last_update_submitted_qc>June 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>portal vein pulsatility</keyword>
  <keyword>physiologic volume overload</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

